Notícias e Atividades da Otsuka Holdings

Otsuka Holdings é uma das ...

• Forbes Global 2000 (#799);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Otsuka Holdings é uma empresa listada sob o símbolo 4578 (JP).

Otsuka Holdings tem presença direta em 10 países.

Otsuka Holdings possui 25 subsidiárias incluindo Astex, Astex Pharmaceuticals e Cambridge Isotope Laboratories.

Eles estão dentro:

• Farmacêutica54%
• Equipamentos Médicos27%
• Outro19%

Veja o organograma con seus 262 executivos principais

Biografias mais buscadas da Otsuka Holdings

• Tatsuo Higuchi, President, Chief Executive Officer, Chairman of Th...
• Yukio Matsutani, Independent Director
• Ko Sekiguchi, Independent Director

Criar um alerta
para seguir os movimentos de executivos da Otsuka Holdings.

Otsuka Holdings possui 2.066 concorrentes concorrentes UnitedHealth Group (Estados Unidos), Optum (Estados Unidos) e Siemens Healthineers (Alemanha).

Popular M&A news in Saúde

• CareSource adquiriu Commonwealth Care Alliance (publicado em 1 de maio de 2025).
• Nourish acaba de anunciar uma arrecadação de fundos de 70 milhões de dólares. (publicado em 25 de abril de 2025).
• Accolade and Accolade have announced they will merge  (publicado em 9 de abril de 2025)..

Outros contatos sugeridos na indústria do Saúde

• Paulo Junqueira Moll - Chief Executive Officer da Rede D'Or Sao Luiz
• Ari Bousbib - Chairman and Chief Executive Officer da IQVIA
• Bryan Roberts - Director da Included Health

Saiba mais sobre a indústria do Saúde

Últimos comunicados de imprensa de Otsuka Holdings

• Otsuka Pharmaceutical Opens First POCARI SWEAT Factory in VietnamSupporting Health and Meeting Growing Demand｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Files Biologics License Application (BLA) for Sibeprenlimab in the Treatment of Immunoglobulin A Nephropathy｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Pharmaceutical is Focusing on "Water, Nutrition, and Oxygen" to Tap into Human PotentialProvide "Wellness Energy" at Expo 2025 in Osaka, Kansai, Japan｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Pharmaceutical is Expanding "Local Production and Local Recycling" of PET Bottle Initiatives in Cooperation with Local CommunitiesAgreement Signed with the Saga Eastern Environmental Facilities Association for Horizontal Recycling of PET Bottle｜New
• Rxulti® (brexpiprazole) approved in the European Union for the treatment of schizophrenia in adolescents aged 13 years and older｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• HemeSight®, the First-in-Japan Comprehensive Genomic Profiling Assay for Hematological Malignancies, Is Now on Sale - Insurance coverage begins on March 1, 2025｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Pharmaceutical Finalizes an Agreement with Fukuroi City on the Horizontal Recycling of PET BottlesPartnering with Its Factory to Promote a "Local Production and Local Recycling" Initiative for PET Bottles｜News Releases | Otsuka Pharmaceutical Co.,
• Otsuka Sponsor TOKYO MARATHON 2025 Supporting the Conditioning of Runners Worldwide with the Global Brand POCARI SWEAT｜News Releases | Otsuka Pharmaceutical Co., Ltd.
• Otsuka Holdings Receives Award by the Commissioner of the Consumer Affairs Agency at FY2024 Award for Good Practices of Consumer-Oriented Management　- Recognized for Otsuka Pharmaceutical’s Longstanding Efforts to Prevent Heat Disorders- | Otsuka Group Ne
• Otsuka Group Selected for CDP Climate Change A List for a Third Consecutive Year | Otsuka Group News | Otsuka Holdings Co., Ltd.searchsearchBack ButtonSearch IconFilter Icon
• View more press releases Close

Redes sociais sobre Otsuka Holdings

• Otsuka Holdings na Wikipedia, Google News e Yahoo Finance
• Otsuka Holdings na LinkedIn, Twitter e YouTube